Form D · Other Health Care

Saba Labs, LLC

Birmingham, AL · CIK 0001594979

Offering snapshot reported Jul 28, 2017 · SEC filing

Reported sold
$250K
Offering amount: $250K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 20, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 28, 2017Initial$250,000No comparison1SEC filing
Mar 2, 2017AmendmentYet to sellNo comparison8SEC filing
Aug 23, 2016Amendment$850,000$50,000vs Aug 24, 20157SEC filing
Feb 18, 2016InitialYet to sellNo comparison0SEC filing
Aug 24, 2015AmendmentYet to sellNo comparison8SEC filing
Aug 24, 2015Amendment$800,000No comparison6SEC filing
Mar 26, 2015InitialYet to sellNo comparison0SEC filing
Mar 31, 2014AmendmentYet to sellNo comparison0SEC filing
Dec 20, 2013InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-291670

Source: Form D, filed Jul 28, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Hossein Dovlatabadi Director
Bob Jacobus Executive
Madding King Iii Executive
Mading King Iii Director
William A Legg, Jr. Director
Philip White Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
2501 20 Th Place South Suite 275
Birmingham, AL, 35223